Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacson K Shen

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Plastic and Reconstructive Surgery|November 13, 2018
Global Interest in Gender Affirmation Surgery: A Google Trends AnalysisJacson K Shen, Nicole A Seebacher, Shane D Morrison
Oncotarget|October 6, 2017
Noncoding RNA in drug resistant sarcomaXiaoyang Li, Jacson K Shen, Francis J Hornicek, et al.
Oncotarget|April 7, 2016
The emerging roles and therapeutic potential of cyclin-dependent kinase 11 (CDK11) in human cancerYubing Zhou, Jacson K Shen, Francis J Hornicek, et al.
Scientific Reports|May 10, 2017
Wnt inhibitory factor 1 (WIF1) methylation and its association with clinical prognosis in patients with chondrosarcomaPei Liu, Jacson K Shen, Francis J Hornicek, et al.
Biochimica Et Biophysica Acta. Gene Regulatory Mechanisms|December 8, 2016
Regulation of microRNA-1 (miR-1) expression in human cancerChao Han, Jacson K Shen, Francis J Hornicek, et al.
Oncoimmunology|January 23, 2015
Targeting programmed cell death ligand 1 in osteosarcoma: an auto-commentary on therapeutic potentialJacson K Shen, Gregory M Cote, Edwin Choy, et al.
Cancer Letters|January 26, 2016
Development and potential applications of CRISPR-Cas9 genome editing technology in sarcomaTang Liu, Jacson K Shen, Zhihong Li, et al.
Discovery Medicine|December 10, 2015
The emerging roles and therapeutic potential of microRNAs (miRs) in liposarcomaRanran Sun, Jacson K Shen, Edwin Choy, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|February 17, 2018
Expression and therapeutic implications of cyclin-dependent kinase 4 (CDK4) in osteosarcomaYubing Zhou, Jacson K Shen, Zujiang Yu, et al.
Current Medicinal Chemistry|February 11, 2015
Targeted cancer therapy; nanotechnology approaches for overcoming drug resistanceYan Gao, Jacson K Shen, Lara Milane, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Plastic and Reconstructive Surgery|November 13, 2018
Global Interest in Gender Affirmation Surgery: A Google Trends AnalysisJacson K Shen, Nicole A Seebacher, Shane D Morrison
Oncotarget|October 6, 2017
Noncoding RNA in drug resistant sarcomaXiaoyang Li, Jacson K Shen, Francis J Hornicek, et al.
Oncotarget|April 7, 2016
The emerging roles and therapeutic potential of cyclin-dependent kinase 11 (CDK11) in human cancerYubing Zhou, Jacson K Shen, Francis J Hornicek, et al.
Scientific Reports|May 10, 2017
Wnt inhibitory factor 1 (WIF1) methylation and its association with clinical prognosis in patients with chondrosarcomaPei Liu, Jacson K Shen, Francis J Hornicek, et al.
Biochimica Et Biophysica Acta. Gene Regulatory Mechanisms|December 8, 2016
Regulation of microRNA-1 (miR-1) expression in human cancerChao Han, Jacson K Shen, Francis J Hornicek, et al.
Oncoimmunology|January 23, 2015
Targeting programmed cell death ligand 1 in osteosarcoma: an auto-commentary on therapeutic potentialJacson K Shen, Gregory M Cote, Edwin Choy, et al.
Cancer Letters|January 26, 2016
Development and potential applications of CRISPR-Cas9 genome editing technology in sarcomaTang Liu, Jacson K Shen, Zhihong Li, et al.
Discovery Medicine|December 10, 2015
The emerging roles and therapeutic potential of microRNAs (miRs) in liposarcomaRanran Sun, Jacson K Shen, Edwin Choy, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|February 17, 2018
Expression and therapeutic implications of cyclin-dependent kinase 4 (CDK4) in osteosarcomaYubing Zhou, Jacson K Shen, Zujiang Yu, et al.
Current Medicinal Chemistry|February 11, 2015
Targeted cancer therapy; nanotechnology approaches for overcoming drug resistanceYan Gao, Jacson K Shen, Lara Milane, et al.
Pageof 3